Thyroglobulin measurement and postablative iodine-131 total body scan after total thyroidectomy for differentiated thyroid carcinoma in patients with no evidence of disease-Reference-Cited by-同舟云学术

Thyroglobulin measurement and postablative iodine-131 total body scan after total thyroidectomy for differentiated thyroid carcinoma in patients with no evidence of disease

Published:1996-06 Issue:7 Volume:32 Page:1262
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Tenenbaum F.,Corone C.,Schlumberger M.,Parmentier C.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference3 articles.

1. A new immunoradiometric assay (IRMA) system for thyroglobulin measurement in the follow-up of thyroid cancer patients;Schlumberger;Eur J Nucl Med,1991

2. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays;Schlumberger;J Nucl Med,1988

3. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels;Pacini;J Nucl Med,1987

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differentiated Thyroid Cancer: Radioiodine Therapy;Clinical Nuclear Medicine;2020

2. Advantages of dosimetry in 131I therapy of differentiated thyroid carcinoma;The Quarterly Journal of Nuclear Medicine and Molecular Imaging;2019-10

3. Radioiodine Therapy of Thyroid Cancer;Nuclear Medicine Therapy;2019

4. Differentiated Thyroid Cancer: Diagnosis, Therapy, and Follow-Up;Atlas of Thyroid and Neuroendocrine Tumor Markers;2018

5. Is 131I ablation necessary for patients with low-risk papillary thyroid carcinoma and slightly elevated stimulated thyroglobulin after thyroidectomy?;Archives of Endocrinology and Metabolism;2016-02